2000
Innovative, New System Represents Guidant''s Eighth Major Product Approval in Four Months. Market Anticipation of New Coronary Stent Impacts Third Quarter Revenues Indianapolis, Ind. and Santa...
National Institute for Clinical Excellence Recommends Three-Fold Increase in Defibrillator Use Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary and peripheral vascular disease, today announced the start of a clinical trial to determine...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Guidant president and CEO Ron Dollens has been named to the board of directors of the Alliance for Aging Research....
Company to Make Acquisition Decision After Completing Comprehensive Investigation Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry,...
Screening for Abdominal Aortic Aneurysm Also Available in Select Sites for the First Time Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implants of...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received U.S. Food and...
Study Examines Alternative Treatment for Hypertension Caused by Renal Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Patients suffering from high blood pressure caused by renal artery...
Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study show that a new procedure utilizing endoscopic vein harvesting leads to fewer wound healing complications compared to...
INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its planned general briefing at the upcoming American...
Clinical Trial Will Assess Stenting of Cerebral Arteries Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of vascular disease,...
Key Opinion Leaders Attend Day-Long Opening Symposium, Witness Remote Broadcasts of Live Case Demonstrations Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a leading provider of...
World's Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced worldwide market...
Launch of MULTI-LINK PENTA Registry is a Result of Guidant's IDE Filing of Fifth Broad Use Coronary Stent System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...
Guidant Named one of FORTUNE Magazine''s 100 Fastest Growing Companies and IndustryWeek''s 100 Best Managed Companies Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader...
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable defibrillation systems, today announced the company has received FDA approval to...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the company has...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the worldwide market release of the ZOOM(tm)...
Indianapolis, IN and Santa Clara, CA - As part of its comprehensive program to treat carotid artery disease, Guidant Corporation (NYSE and PCX: GDT) has launched a study to evaluate the safety and...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, is today joining a number of the nation''s leading health care companies and...
Indianapolis, IN and Santa Clara, CA - Patients at risk of experiencing life-threatening abrupt closures in small blood vessels may soon benefit from new technology developed to prevent blocked...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), today announced all-time record sales of $668.4 million for the second quarter of 2000, an increase of 9 percent over the second quarter...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced that the CONTAK CD heart failure device...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery disease, today announced FDA marketing clearance for two new...